Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy

被引：0
|
作者：
Moreno, S. Flores [1 ]
Paloma, J. Bautista [2 ]
机构：
[1] Andalusian Agcy Hlth Technol Assessment, Seville 41006, Spain
[2] Virgen Rocio Hosp, Seville, Spain
来源：
BRITISH JOURNAL OF OPHTHALMOLOGY | 2008年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：866 / 867
页数：8
相关论文
共 50 条
  • [41] Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
    Kanoff, Justin
    Miller, Joan
    SEMINARS IN OPHTHALMOLOGY, 2013, 28 (5-6) : 355 - 360
  • [42] Ranibizumab for Age-Related Macular Degeneration
    Cheng, Jin-Wei
    Wei, Rui-Li
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 582 - 582
  • [43] Ranibizumab for Age-related Macular Degeneration
    Seider, Michael I.
    Stewart, Jay M.
    OPHTHALMOLOGY, 2011, 118 (08) : 1693 - 1694
  • [44] Therapeutic effects of ranibizumab in neovascular age-related macular degeneration
    Ciulla, Thomas A.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 679 - 693
  • [45] Ranibizumab for age-related macular degeneration
    Dhoot, Dilsher S.
    Kaiser, Peter K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (03) : 371 - 381
  • [46] Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update
    Parravano, Mariacristina
    Costanzo, Eliana
    Scondotto, Giulia
    Trifiro, Gianluca
    Virgili, Gianni
    BIODRUGS, 2021, 35 (06) : 673 - 692
  • [47] Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
    Yang, Shiqi
    Zhao, Jingke
    Sun, Xiaodong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1857 - 1867
  • [48] Glaucoma Tube Outcomes with and without Anti-VEGF in Patients with Age-related Macular Degeneration
    Rothman, Adam L.
    Beca, Flavius A.
    Tijerina, Jonathan D.
    Schuman, Darren M.
    Parrish II, Richard K.
    Vanner, Elizabeth A.
    Liu, Katy C.
    OPHTHALMOLOGY GLAUCOMA, 2024, 7 (03): : 260 - 270
  • [49] Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
    Borrelli, Enrico
    Foti, Claudio
    Ulla, Lorena
    Porreca, Annamaria
    Introini, Ugo
    Grassi, Maria Oliva
    Viggiano, Pasquale
    Peronetti, Mario
    Toscani, Rebecca
    Boscia, Giacomo
    Termite, Alba Chiara
    Gennaro, Carlo
    Marolo, Paola
    Boscia, Francesco
    Bandello, Francesco
    Reibaldi, Michele
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2025,
  • [50] Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
    Wykoff, Charles C.
    Clark, W. Lloyd
    Nielsen, Jared S.
    Brill, Joel V.
    Greene, Laurence S.
    Heggen, Cherilyn L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (02): : S3 - S15
12345